[The results of using lucetam in patients with moderate cognitive impairment of different genesis].
Batysheva
T T
TT
Otcheskaia
O V
OV
Nesterova
O N
ON
Lisinker
L N
LN
Bobina
L A
LA
Ismailov
A M
AM
Shekkhirimov
R K
RK
Zhuravleva
E Iu
EIu
Kamchatnov
P R
PR
Boĭko
A N
AN
D000368:Aged; D001927:Brain Diseases / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D003071:Cognition / Q000187:drug effects / Q000502:physiology*; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D018697:Nootropic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D010889:Piracetam / Q000008:administration & dosage / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D018697:Nootropic Agents; D010889:Piracetam